Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cyclophosphamide/prednisone/vincristine

Demand ischaemia and respiratory failure: 2 case reports

    • 6 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Saygin C, et al. Outcomes of the cyclophosphamide, vincristine, prednisone (CVP) +/- rituximab (R-CVP) regimen in older patients with newly diagnosed Ph- acute lymphoblastic leukemia. Leukemia Research 89: Feb 2020. Available from: URL: http://doi.org/10.1016/j.leukres.2020.106297

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Cyclophosphamide/prednisone/vincristine. Reactions Weekly 1791, 84 (2020). https://doi.org/10.1007/s40278-020-74929-6

    Download citation